Kenneth J. Hillan - Chief Therapeutics Officer at Chrome Holding Co.

Issuer-level insider activity

Role
Chief Therapeutics Officer
Issuer ticker
ME
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Kenneth J. Hillan since 03 Aug 2025

Reported holdings for Kenneth J. Hillan in Chrome Holding Co.

Form 4 holding Chief Therapeutics Officer

23andMe Holding Co.

Security class
Class A Common Stock
Shares / value
221,876
Estimated value
$158,752
Report date
05 Jun 2023
Price
$0.7155
Ownership
Direct

Transaction history for Kenneth J. Hillan in Chrome Holding Co.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .